The serotonin reuptake inhibitor Paroxetin is superior to the Noradrenaline reuptake inhibitor Maprotiline in the treatment of premenstrual syndrome. - Eriksson,E.; Hedberg,M.; Andersch,B.; Sundblad,C. (Neuropsychopharmacology, 1995)